Analysts Remain Bullish on FedEx Stock Despite Weak Earnings

Plus, Amazon could be working on a new product

Sep 20, 2017 at 9:43 AM
facebook twitter linkedin

Stocks are searching for direction out of the gate this morning ahead of the Fed's afternoon policy announcement. Among specific stocks in focus today are e-commerce giant, Inc. (NASDAQ:AMZN), delivery concern FedEx Corporation (NYSE:FDX), and biopharmaceutical company Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Here's a closer look at what's moving shares of AMZN, FDX, and ALNY. 

AMZN Stock Looks to Rise on Smart Glasses Buzz

Amazon is working on a pair of "smart glasses," according to a report from the Financial Times. As such, the stock is up fractionally today to trade at $971.20. While this is far removed from the shares' record high of $1,083.31, from July 27, they recently bounced from the $939.51 level, which corresponds to a 23.6% Fibonacci retracement of their 2016 low and 2017 peak. This level contained AMZN's June pullback, before the equity rallied to record highs. 

Analysts certainly have high hopes. Most notably, Amazon has an average 12-month price target of $1,147.28 -- representing 18.1% upside from the shares' current perch. 

Weak Profits Ding FedEx Stock

Shares of FedEx are up 1% this morning at $218.16, even after the company announced lower-than-expected fiscal first-quarter earnings. Raymond James responded by raising its price target to $232 from $228, in record-high territory. Plus, FDX stock remains 17.5% higher on a year-over-year basis. This could explain why analysts are so bullish -- unlike options traders. As it stands now, 12 of 16 covering brokerage firms say to buy the equity. 

Alnylam Pharmaceuticals Hits Fresh Highs After Drug Trial

Alnylam Pharmaceuticals has exploded 33% out of the gate to trade at $99.75 -- and touched a 52-week high of $100 earlier -- after the company's genetic disease treatment, patisiran, met its goals in a late-stage study. The shares now boast a year-to-date lead of 166%, and more upside could be in store if short sellers continue to cover their positions. These bearish bets declined by 6.5% during the two most recent reporting periods, but 11.6% of ALNY's float is still dedicated to short interest. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 


300x250 - Banner 3 - v1